NEW YORK (Reuters Health) – Among pediatric patients undergoing surgical repair of congenital heart defects, the use of milrinone to reduce the risk of low cardiac output syndrome…
NEW YORK (Reuters Health) – The dyspnea related to use of ticagrelor rather than clopidogrel in patients with acute coronary syndromes (ACS) is not associated with pulmonary function,…
NEW YORK (Reuters Health) – More than two-thirds of patients prescribed pitavastatin after an acute MI achieve target LDL cholesterol levels, and clinical outcomes are generally favorable, according…
NEW YORK (Reuters Health) – While fluoroquinolones may be a preferred option in children in some clinical situations, concerns about safety persist and physicians should be aware of…
NEW YORK (Reuters Health) – Pretreatment with a 600-mg versus a standard 300-mg loading dose of clopidogrel in the setting of urgent percutaneous coronary intervention for ST-segment elevated…
NEW YORK (Reuters Health) – An observational study conducted in the Netherlands finds that unexplained acute pancreatitis is often associated with drugs that can cause the condition, but…
NEW YORK (Reuters Health) – Treating patients with ischemic stroke up to 22 hours after onset with the glycoprotein IIb/IIIa platelet receptor antagonist tirofiban does not increase cerebral…
NEW YORK (Reuters Health) – Continuing bivalirudin for 4 hours after primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) facilitates early microvascular reperfusion without an…
NEW YORK (Reuters Health) – Treatment of skin and soft-tissue infections (SSTIs) in children in regions where community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is prevalent is more likely to…
NEW YORK (Reuters Health) – A novel glucose-lowering drug, dapagliflozin, improves glycemic control in patients with type 2 diabetes already on metformin, and it promotes significant weight loss,…